Profil
Mr. Jamal El-Mosleh is a Chief Executive Officer at Elicera Therapeutics AB. Mr. El-Mosleh was previously employed as a Chief Executive Officer by Annexin Pharmaceuticals AB and a Chief Executive Officer & IR Contact by Immunicum AB. He also served on the board at Elypta AB. He received his graduate degree from Chalmers University of Technology and a graduate degree from Chalmers School of Entrepreneurship.
Postes actifs de Jamal El-Mosleh
| Sociétés | Poste | Début |
|---|---|---|
| ELICERA THERAPEUTICS AB | Directeur Général | 01/01/2020 |
Anciens postes connus de Jamal El-Mosleh
| Sociétés | Poste | Fin |
|---|---|---|
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Directeur/Membre du Conseil | 01/01/2020 |
| ANNEXIN PHARMACEUTICALS AB | Directeur Général | 01/01/2019 |
| MENDUS AB | Directeur Général | 01/10/2016 |
Formation de Jamal El-Mosleh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mendus AB
Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer | Health Technology |
Chalmers School of Entrepreneurship
Chalmers School of Entrepreneurship Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Annexin Pharmaceuticals AB
Annexin Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures drugs for cardiovascular diseases | Health Technology |
Elypta AB
Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Elicera Therapeutics AB
Elicera Therapeutics AB BiotechnologyHealth Technology Develops and trades cell and gene therapies in immune-oncology | Health Technology |
















